The induction of immunological memory to serogroup A and C polysaccharides
in UK infants immunized with three doses of a meningococcal A/C oligosaccha
ride CRM197 conjugate vaccine was investigated. Forty UK infants vaccinated
previously with three doses of a meningococcal A/C oligosaccharide-CRM197
conjugate vaccine at 2, 3 and 4 months of age, were revaccinated at a mean
age of 145.6 weeks with either a 10 or 50 mu g dose of licensed meningococc
al A/C polysaccharide vaccine. Serogroup-specific antibody and serum bacter
icidal antibody (SBA) responses were measured by enzyme-linked immunosorben
t assay and serum bactericidal assays, respectively. Following challenge, a
nti-serogroup A and C polysaccharide antibody levels rose from pro-booster
geometric mean concentrations (GMC) of 3.1 and 2.1 mu g/ml respectively to
19.6 and 21.0 mu g/ml 1 month post-booster. Serum bactericidal antibody geo
metric mean titres (GMTs) for serogroups A and C increased 156- and 113-fol
d from 2.1 and 7.1 pro-booster respectively to 327.4 and 800.7 post-booster
. A serogroup A control group of 45 children received a 10 mu g dose of lic
ensed meningococcal A/C polysaccharide vaccine (with no prior history of se
rogroup A vaccination) had serogroup A SEA GMTs of 2.3 prevaccination risin
g to 8 post-vaccination with corresponding GMCs of 0.8 and 10.8 mu g/ml. Th
ese rises in SEA following serogroup A/C conjugate vaccination are indicati
ve of immunological priming.